Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

SEI lists what managers face when launching alternative investment strategies in regulated mutual fund or UCITS format

Wednesday, November 30, 2011
Opalesque Industry Update - SEI released their latest paper entitled Regulated Alternative Funds: The New Conventional, which evaluates the opportunities and challenges managers face when launching and distributing alternative investment strategies in a registered mutual fund or UCITS format. Key finding below:

  • Global financial crises and continued market volatility have transformed attitudes toward investing. As managers respond to the evolving needs of investors and their advisors, previously segregated products and segments are converging.
  • The convergence is seen in growing capital flows into regulated alternative investment products, most often in the form of UCITS funds and US-registered mutual funds.
  • During the first half of 2011, more than $58 billion was poured into regulated funds using alternative strategies. With no slowdown of demand in sight, assets in alternative mutual funds and UCITS could hit the $1 trillion mark by 2014.
  • Growth is being driven by several factors:

1. Investors are looking for ways to bolster portfolio performance, protect capital, and lower volatility.
2. Traditional managers want to tap higher-fee areas.
3. Alternative managers would like to expand and diversify their client base.

  • Alternative strategies still account for a small portion of the UCITS and US mutual fund markets, but they continue to capture increased market share. They are also the most popular category in product development pipelines.
  • Alternative strategies inside UCITS attracted $27 billion of net new flows in the first half of 2011, 26% higher than in the second half of last year. This was achieved despite overall flows into long-term UCITS declining by over 50% during the same period. There are now over 1,500 UCITS funds in Europe using alternative strategies and managing a combined $254 billion of assets.
  • Alternative strategies through US mutual funds and ETFs drew $39 billion in net inflows in the first eight months of 2011, on pace to come near 2010’s $65 billion. By the end of September 2011, the US had roughly 760 alternative mutual funds and ETFs, 150 of which had been launched in the first nine months of 2011 alone.
  • Regulators remain concerned with the growth of derivatives use among regulated funds and have been reviewing derivatives policy for more than a year. The SEC has gone so far as to freeze most approvals of new funds and ETFs that rely heavily on derivatives, as it continues to conduct its review.
  • The future of alternative investments through regulated funds hinges to a large degree on robust risk management. Fund managers assume primary responsibility for implementing the necessary controls, but independent service providers also play important roles. Investors can also take some comfort in detailed regulatory requirements around risk measurement and management, liquidity, counterparty diversification, and limits on leverage.
  • Despite becoming increasingly competitive, the market for regulated alternative funds remains much more fragmented than traditional parts of the business, and no dominant players have yet emerged. As managers jockey for position and vie for the attention of investors, intermediaries, and gatekeepers, product innovation and distribution expertise will be key factors in determining the winners.
  • Partnerships that combine the investment expertise of existing alternative managers with the distribution prowess of traditional managers will become more common as managers of all stripes look for ways to gain a foothold in one of the most dynamic and growing parts of the asset management business.

(Press release)

Access full report here: Source

SEI's Investment Manager Services division provides comprehensive operational outsourcing solutions to support investment managers globally across a range of registered and unregistered fund structures, diverse investment strategies and jurisdictions. The division has been recently recognised by the Money Management Institute as "Service Provider of the Year," by Buy-Side Technology as "Best Fund Administrator" and by HFMWeek as "Best Single Manager Hedge Fund Administrator (Over US$30B AUA—US),” and “Best Funds of Hedge Funds Administrator (Over US$30B AUA—Europe)." www.seic.com/enUK/investment-managers.htm

BG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for